Drug Risks Emerge Early at Scale

When millions or billions start a medication, researchers immediately accumulate massive 'person-time,' letting them spot even rare adverse events quickly. This is like tracking millions of device-hours to estimate failure rates without waiting years. The result is that truly dangerous drugs usually trigger early safety signals and get pulled fast. — It challenges long-horizon fear narratives about medicines and supports evidence-based risk communication and policy.